Literature DB >> 16002098

The potential role of sigma-1 receptors in lipid transport and lipid raft reconstitution in the brain: implication for drug abuse.

Teruo Hayashi1, Tsung-Ping Su.   

Abstract

The brain is highly enriched in lipids. However, the molecular biological roles of lipids in the brain have been largely unexplored. Although, in 1990s, several studies have demonstrated the roles of lipids in a variety of neuronal functions and certain neurological diseases, the involvement of lipids in drug dependence, if any, is almost totally unknown. Sigma-1 receptors are brain-enriched proteins that interact with psychostimulants such as cocaine and methamphetamine. Sigma-1 receptors possess a putative sterol-binding pocket and are predominantly expressed on the endoplasmic reticulum (ER) where most lipids and their precursors are synthesized. Sigma-1 receptors are involved in drug-seeking behaviors and in psychostimulant-induced behavioral sensitization. Recent studies demonstrated that sigma-1 receptors target the lipid-storing subcompartments of the ER and are colocalized with cholesterol and neutral lipids. Sigma-1 receptors form detergent-insoluble lipid microdomains (lipid rafts) on the ER subcompartments and can translocate on the ER when stimulated. Upregulation of sigma-1 receptors affect the levels of plasma membrane lipid rafts by changing the lipid components therein. The membrane reconstitution thus induced by sigma-1 receptors in turn affects functions of proteins residing in plasma membrane lipid rafts including tropic factor receptors and tyrosine kinases. Specifically, we recently found that sigma-1 receptors modulate MAP kinase activation induced by tropic factors, neuritegenesis and oligodendrocyte differentiation-all related to lipid raft reconstitution. Sigma-1 receptors may thus play a role in psychostimulant-induced long-lasting morphological changes in the brain via the capacity of sigma-1 receptors in regulating ER lipid transport and the resultant plasma membrane lipid raft reconstitution.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16002098     DOI: 10.1016/j.lfs.2005.05.009

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  31 in total

1.  Overexpression of sigma-1 receptor inhibits ADAM10 and ADAM17 mediated shedding in vitro.

Authors:  Juan Li; Bin Liu; Xiaofei Gao; Zhixing Ma; Tianyi CaoSong; Yan-ai Mei; Yufang Zheng
Journal:  Protein Cell       Date:  2012-02-09       Impact factor: 14.870

2.  Molecular mechanisms involving sigma receptor-mediated induction of MCP-1: implication for increased monocyte transmigration.

Authors:  Honghong Yao; Yanjing Yang; Kee Jun Kim; Crystal Bethel-Brown; Nan Gong; Keiko Funa; Howard E Gendelman; Tsung-Ping Su; John Q Wang; Shilpa Buch
Journal:  Blood       Date:  2010-03-30       Impact factor: 22.113

3.  The sigma receptor: evolution of the concept in neuropsychopharmacology.

Authors:  T Hayashi; Tp Su
Journal:  Curr Neuropharmacol       Date:  2005-10       Impact factor: 7.363

4.  Differential sensitivity of A2A and especially D2 receptor trafficking to cocaine compared with lipid rafts in cotransfected CHO cell lines. Novel actions of cocaine independent of the DA transporter.

Authors:  Susanna Genedani; Chiara Carone; Diego Guidolin; Monica Filaferro; Daniel Marcellino; Kjell Fuxe; Luigi Francesco Agnati
Journal:  J Mol Neurosci       Date:  2010-02-09       Impact factor: 3.444

5.  (+)-Morphine attenuates the (-)-morphine-produced tail-flick inhibition via the sigma-1 receptor in the mouse spinal cord.

Authors:  Leon F Tseng; Quinn H Hogan; Hsiang-En Wu
Journal:  Life Sci       Date:  2011-10-02       Impact factor: 5.037

6.  Sigma receptors [σRs]: biology in normal and diseased states.

Authors:  Colin G Rousseaux; Stephanie F Greene
Journal:  J Recept Signal Transduct Res       Date:  2015-06-09       Impact factor: 2.092

Review 7.  A role for sigma receptors in stimulant self-administration and addiction.

Authors:  Jonathan L Katz; Weimin C Hong; Takato Hiranita; Tsung-Ping Su
Journal:  Behav Pharmacol       Date:  2016-04       Impact factor: 2.293

8.  In vitro effects of cocaine on tunneling nanotube formation and extracellular vesicle release in glioblastoma cell cultures.

Authors:  Chiara Carone; Susanna Genedani; Giuseppina Leo; Monica Filaferro; Kjell Fuxe; Luigi Francesco Agnati
Journal:  J Mol Neurosci       Date:  2014-07-05       Impact factor: 3.444

Review 9.  The neuropharmacology of relapse to food seeking: methodology, main findings, and comparison with relapse to drug seeking.

Authors:  Sunila G Nair; Tristan Adams-Deutsch; David H Epstein; Yavin Shaham
Journal:  Prog Neurobiol       Date:  2009-06-02       Impact factor: 11.685

10.  Pharmacology and therapeutic potential of sigma(1) receptor ligands.

Authors:  E J Cobos; J M Entrena; F R Nieto; C M Cendán; E Del Pozo
Journal:  Curr Neuropharmacol       Date:  2008-12       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.